| Item Type | Name |
|
Concept
|
Angina Pectoris
|
|
Academic Article
|
Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.
|
|
Academic Article
|
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
|
|
Academic Article
|
Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina.
|
|
Academic Article
|
Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
|
|
Academic Article
|
The risk of cardiovascular side effects with anti-anginal drugs.
|
|
Academic Article
|
Drug Therapy for Stable Angina Pectoris.
|
|
Academic Article
|
Efficacy of isosorbide mononitrate in angina pectoris.
|
|
Academic Article
|
Role of nitrates in angina pectoris.
|
|
Academic Article
|
Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group.
|
|
Academic Article
|
Assessment of "optimal" beta blockade in treating patients with angina pectoris.
|
|
Academic Article
|
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
|
|
Academic Article
|
Beta adrenergic blocking agents for exertional angina pectoris.
|
|
Academic Article
|
Short and long-acting oral nitrates for stable angina pectoris.
|
|
Academic Article
|
Ointments and transdermal nitroglycerin patches for stable angina pectoris.
|
|
Academic Article
|
Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial.
|
|
Academic Article
|
Treatment of stable angina.
|
|
Academic Article
|
Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris.
|
|
Academic Article
|
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
|
|
Academic Article
|
Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable angina: yet another failed strategy to prevent tolerance.
|
|
Academic Article
|
Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction.
|
|
Academic Article
|
Therapy of stable angina pectoris: the uncomplicated patient.
|
|
Academic Article
|
Nitrate tolerance. How to prevent it or minimize its effect.
|
|
Academic Article
|
Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
|
|
Academic Article
|
Medical therapy of stable angina pectoris.
|
|
Academic Article
|
Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance.
|
|
Academic Article
|
Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
|
|
Academic Article
|
The effectiveness of transcutaneous nitrate preparations for angina pectoris.
|
|
Academic Article
|
Nitrate therapy: continuous or pulse dosing.
|
|
Academic Article
|
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.
|
|
Academic Article
|
Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with angina pectoris.
|
|
Academic Article
|
Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
|
|
Academic Article
|
Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.
|
|
Academic Article
|
Mononitrates: defining the ideal long-acting nitrate.
|
|
Academic Article
|
Duration of effects of isradipine during twice daily therapy in angina pectoris.
|
|
Academic Article
|
Conversion from immediate-release to extended-release diltiazem in angina pectoris.
|
|
Academic Article
|
Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.
|
|
Academic Article
|
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
|
|
Academic Article
|
Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
|
|
Academic Article
|
Influence of glyceryl trinitrate during supine and upright exercise in patients with angina pectoris.
|
|
Academic Article
|
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
|
|
Academic Article
|
Current medical management of chronic stable angina.
|
|
Academic Article
|
Can nicorandil treat angina pectoris effectively?
|
|
Academic Article
|
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial.
|
|
Academic Article
|
Long-term bepridil monotherapy for angina pectoris.
|
|
Academic Article
|
Improvement in angina pectoris with alpha adrenoceptor blockade.
|
|
Academic Article
|
Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
|
|
Academic Article
|
Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.
|
|
Academic Article
|
Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance.
|
|
Academic Article
|
Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
|
|
Academic Article
|
Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
|
|
Academic Article
|
Kinetics of isosorbide dinitrate and relationships to pharmacological effects.
|
|
Academic Article
|
Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectoris.
|
|
Academic Article
|
Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible?
|
|
Academic Article
|
Propranolol in angina pectoris: comparison of therapy given two and four times daily.
|
|
Academic Article
|
Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.
|
|
Academic Article
|
Nitrate therapy and the development of tolerance.
|
|
Academic Article
|
Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data?
|
|
Academic Article
|
Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
|
|
Academic Article
|
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
|
|
Academic Article
|
Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
|
|
Academic Article
|
Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris.
|
|
Academic Article
|
Side effects of using nitrates to treat angina.
|
|
Academic Article
|
Exercise performance, physical activity, and health-related quality of life in participants with stable angina.
|
|
Academic Article
|
Chronic stable angina pectoris.
|
|
Academic Article
|
Slow release oxprenolol in angina pectoris [proceedings].
|
|
Academic Article
|
Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
|
|
Academic Article
|
Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise.
|
|
Academic Article
|
Clinical, hemodynamic and metabolic responses during pacing in the supine and sitting postures in patients with angina pectoris.
|
|
Academic Article
|
Reproducibility of clinical and hemodynamic parameters during pacing stress testing in patients with angina pectoris.
|
|
Academic Article
|
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
|
|
Academic Article
|
Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy.
|
|
Academic Article
|
Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease.
|
|
Academic Article
|
Oxprenolol in angina pectoris [proceedings].
|
|
Academic Article
|
Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study.
|
|
Academic Article
|
Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
|
|
Academic Article
|
Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
|
|
Academic Article
|
Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
|
|
Academic Article
|
Comparison of adrenergic beta-receptor antagonists in angina pectoris.
|
|
Academic Article
|
Cardiovascular effects of weight reduction in obese patients with angina pectoris.
|
|
Academic Article
|
Proceedings: Left ventricular pressure-volume changes during exercise-induced pain in patients with angina pectoris.
|
|
Academic Article
|
Chronic stable angina pectoris. Strategies for effective drug therapy.
|
|
Academic Article
|
Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators.
|
|
Academic Article
|
Oral nitrates: more than symptomatic therapy in coronary artery disease?
|